+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vectura Group plc - logo

Vectura Pharma was established in 1997, and its headquarters are in Chippenham in the U.K. Vectura Group plc researches, develops, and commercializes novel therapeutic products and drug delivery systems for the treatment of airways-related diseases Vectura entered into its first global commercialisation and development agreement with Novartis for NVA237. The company’s marketed products include Ultibro Breezhaler and Seebri Breezhaler for the treatment of chronic obstructive pulmonary disease (COPD).

From
Cystic Fibrosis - Pipeline Review, H2 2020 - Product Thumbnail Image

Cystic Fibrosis - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 550 pages
From
From
From
Vectura Group Plc (VEC) - Product Pipeline Analysis, 2020 Update - Product Thumbnail Image

Vectura Group Plc (VEC) - Product Pipeline Analysis, 2020 Update

  • Company Profile
  • January 2021
  • 48 pages
From
From
Vectura Group plc - Strategy, SWOT and Corporate Finance Report - Product Thumbnail Image

Vectura Group plc - Strategy, SWOT and Corporate Finance Report

  • SWOT Analysis
  • January 2021
  • 44 pages
From
Vectura Group PLC - Product Thumbnail Image

Vectura Group PLC

  • Company Profile
  • August 2021
  • 70 Pages
Loading Indicator
adroll